Kennedy, Alyssa L. http://orcid.org/0000-0001-7948-5933
Myers, Kasiani C. http://orcid.org/0000-0002-5528-4405
Bowman, James
Gibson, Christopher J.
Camarda, Nicholas D. http://orcid.org/0000-0002-1853-0056
Furutani, Elissa
Muscato, Gwen M.
Klein, Robert H.
Ballotti, Kaitlyn
Liu, Shanshan
Harris, Chad E.
Galvin, Ashley
Malsch, Maggie
Dale, David
Gansner, John M. http://orcid.org/0000-0002-4030-3044
Nakano, Taizo A.
Bertuch, Alison
Vlachos, Adrianna
Lipton, Jeffrey M.
Castillo, Paul http://orcid.org/0000-0002-2813-1729
Connelly, James
Churpek, Jane
Edwards, John R.
Hijiya, Nobuko
Ho, Richard H.
Hofmann, Inga
Huang, James N.
Keel, Siobán
Lamble, Adam
Lau, Bonnie W.
Norkin, Maxim
Stieglitz, Elliot http://orcid.org/0000-0001-7032-4623
Stock, Wendy
Walkovich, Kelly
Boettcher, Steffen
Brendel, Christian
Fleming, Mark D. http://orcid.org/0000-0003-0948-4024
Davies, Stella M.
Weller, Edie A.
Bahl, Christopher
Carter, Scott L. http://orcid.org/0000-0002-8480-1475
Shimamura, Akiko
Lindsley, R. Coleman http://orcid.org/0000-0001-9822-806X
Funding for this research was provided by:
The Butterfly Guild
Article History
Received: 29 July 2020
Accepted: 29 January 2021
First Online: 26 February 2021
Competing interests
: J.R.E. is a part of the speakers’ Bureau: Jazz Pharmaceuticals; Astellas, Consultant: Jazz Pharmaceuticals. N.H. is a consultant for Novartis and Incyte. S.M.D. is a consultant for Alexion and Novartis. R.C.L. has received research funding from Jazz Pharmaceuticals, and consulting fees from Takeda Pharmaceuticals and bluebird bio. Other authors have no competing interests to declare.